Global PET SPECT Market (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) to be US$ 10.3 Billion by 2015

November 10, 2010

DALLAS, November 10, 2010 /PRNewswire/ — The report analyzes the PET
SPECT Market (
http://www.marketsandmarkets.com/Market-Reports/pet-market-98.html) by
technologies and applications and studies the major market drivers,
restraints, and opportunities for the PET SPECT market in U.S., EMEA, and

Browse market data tables and in-depth TOC on Advanced PET (Positron
Emission Tomography) & SPECT (Single Photon Emission Computed Tomography)
Global Market (2010 -2015)

Early buyers will receive 10% customization of reports.

Propelled by the transparent reimbursement policies, new emerging
economies, novel applications such as Alzheimer’s and continually expanding
oncology application segment, the global positron emission tomography (PET)
market is estimated to reach around $6.3 billion in 2010.

Reimbursement plays a major role in the adoption of any medical imaging
technology. The approval of PET scanning reimbursement in the U.S. by the
Medicare and Medicaid for the Alzheimer’s disease widened the opportunities
for the major market participants. Currently, there are approximately 4.7
million Alzheimer’s patients in the U.S. PET enables the radiologist to have
the early diagnosis of the Alzheimer disease among the patients. Therefore,
this would further increase the demand of the PET scanners among the various
health care centers.

Similarly, single photon emission computed tomography (SPECT) scanners
have been on the forefront to bring about significant changes in the
diagnostic imaging equipment landscape by opening up numerous lucrative
opportunities in niche market such as neuroendocrine tumor imaging. Moreover,
technological advancements such as attenuation correction and image
acquisition/reconstruction tools have enhanced SPECT end users’ confidence in
its diagnostic and prognostic capabilities. The global PET SPECT market is
expected to grow from an estimated $6.5 billion in 2010 to $10.3 billion in
2015, at an estimated CAGR of 9.4% from 2010 to 2015. The PET segment is
estimated to account for the largest share – i.e. 75% – of the overall PET
SPECT installations at 3,691 units in 2010. This segment is expected to reach
6,390 units in 2015, at a CAGR of 11.6% for the same period.

The PET/CT segment accounted for the largest share – i.e. 97% – of the
overall PET market at an estimated $6.1 billion in 2010. This segment is
expected to reach $ 9.8 billion in 2015, at a CAGR of 9.8% for the period
2010 to 2015. Oncology and cardiology are the most significant applications
of the PET SPECT market. Oncology accounts for about 90% of the PET market,
whereas cardiology accounts for about 85% of SPECT application market.
Neurological application of PET and SPECT is a niche market and is dependent
on the development of appropriate radionuclides and tracers.

Scope of the report

This research report categorizes the global PET SPECT market on the basis
of technology, application, and geography; forecasting revenues and analyzing
trends in each of the following submarkets:

    - On the basis of technology:
        - Stand alone PET, PET/CT, stand alone SPECT and SPECT/CT
    - On the basis of application:
        - Oncology, non small cell lung cancer, Hodgkin and non Hodgkin
          lymphoma, head and neck cancer, colorectal cancer, breast cancer;
          cardiology and neurology
    - On the basis of geography:
        - U.S., EMEA (Europe, Middle East and Africa), Asia-Pacific and
          Rest of the world

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting
company based in the U.S. We publish strategically analyzed market research
reports and serve as a business intelligence partner to Fortune 500 companies
across the world. MarketsandMarkets also provides multi-client reports,
company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials,
automotive and transportation, banking and financial services, biotechnology,
chemicals, consumer goods energy and power, food and beverages, industrial
automation, medical devices, pharmaceuticals, semiconductor and electronics,
and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by
providing apt business insight with our huge market intelligence repository.
To know more about us and our reports, please visit our website

    Ms. Sunita
    7557 Rambler Road
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    Email: sales@marketsandmarkets.com




SOURCE MarketsandMarkets

Source: newswire

comments powered by Disqus